POLATUZUMAB VEDOTIN
UNII KG6VO684Z6

Substance Identification & Data

This profile provides standardized clinical and technical data for Polatuzumab Vedotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KG6VO684Z6.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1313206-42-6 and the RxNorm Concept ID (RxCUI) 2174090. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

KG6VO684Z6

CAS Registry Number

1313206-42-6

RxNorm Concept ID

2174090

Detailed Substance Profile

Preferred Name

POLATUZUMAB VEDOTIN

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

KG6VO684Z6

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C104153

National Cancer Institute reference terminology for clinical and research data.

INN ID

9714

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

AB-130

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Polatuzumab Vedotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

POLATUZUMAB VEDOTIN

POLATUZUMAB VEDOTIN-PIIQ

Common Names & Synonyms

ANTI-CD79B ADC

ANTI-CD79B ANTIBODY-DRUG CONJUGATE, ANTI-CD79B-VC-MMAE

ANTI-CD79B MONOCLONAL ANTIBODY CONJUGATED TO MONOMETHYL AURISTATIN E (MMAE)

IMMUNOGLOBULIN G1-KAPPA AURISTATIN E CONJUGATE, ANTI-(HOMO SAPIENS CD79B (IMMUNOGLOBULIN-ASSOCIATED CD79 BETA)), HUMANIZED MONOCLONAL ANTIBODY CONJUGATED TO AURISTATIN E

POLATUZUMAB VEDOTIN [INN]

POLATUZUMAB VEDOTIN [JAN]

POLATUZUMAB VEDOTIN [MI]

POLATUZUMAB VEDOTIN [USAN]

POLATUZUMAB VEDOTIN [WHO-DD]

POLATUZUMAB VEDOTIN PIIQ [WHO-DD]

Brand / Trade Names

POLIVY

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN GENE B29 PROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL MCDS4409A HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MCDS4409A .KAPPA.-CHAIN, DIMER, THIOETHER WITH N-(((4-((N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)-L-VALYL-N5-(AMINOCARBONYL)-L-ORNITHYL)AMINO)PHENYL)METHOXY)CARBONYL)-N-METHYL-L-VALYL-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-HYDROXY-1-METHYL-2-PHENYLETHYL)AMINO)-1-METHOXY-2-METHYL-3-OXOPROPYL)-1-PYRROLIDINYL)-2-METHOXY-1-((1S)-1-METHYLPROPYL)-4-OXOBUTYL)-N-METHYL-L-VALINAMIDE

SYS